Concepedia

Author

Karen Schweikart

National Cancer Institute

Also Known As

K Schweikart, Karen M Schweikart, Karen M. Schweikart, Karen Schweikart

17

Publications

542

Citations

10

H-Index

35

Concepts

All Affiliations

National Cancer InstituteSouthern Research InstituteUniversity of Alabama at BirminghamMayo ClinicScience Applications International Corporation (United States)
KS

About

Karen Schweikart is an author at National Cancer Institute specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

236

2

Biochemistry

2

2

111

3

Endocrinology

2

2

37

4

Public Health

1

1

19

5

Social Sciences

1

1

29

Karen Schweikart

×

9

Publications

520

Citations

9

H-Index

YearCitations

SJG-136 (NSC 694501), a Novel Rationally Designed DNA Minor Groove Interstrand Cross-Linking Agent with Potent and Broad Spectrum Antitumor Activity

John A. Hartley, Victoria J. Spanswick, Natalie Brooks,

Cancer Research

2004

137

Preclinical Pharmacology and Toxicology of Intravenous MV-NIS, an Oncolytic Measles Virus Administered With or Without Cyclophosphamide

Rae Myers, Suzanne Greiner, Mia Harvey,

Clinical Pharmacology & Therapeutics

2007

124

Toxicology and pharmacokinetics of 1-methyl-d-tryptophan: Absence of toxicity due to saturating absorption

Lee Jia, Karen Schweikart, Joseph E. Tomaszewski,

Food and Chemical Toxicology

2007

93

Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-Δ24-RGD, in anticipation of a phase I trial for recurrent ovarian cancer

John G. Page, Baohong Tian, Karen Schweikart,

American Journal of Obstetrics and Gynecology

2007

40

The effects of jaspamide on human cardiomyocyte function and cardiac ion channel activity

Karen Schweikart, Liang Guo, Zachary Shuler,

Toxicology in Vitro

2012

37

Sensory nerve conduction of the plantar nerve compared with other nerve conduction tests in rats

Katsumi Kurokawa, Diogo Fraxino de Almeida, Yun Zhang,

Clinical Neurophysiology

2004

29

Identifying the Safety Profile of Ad5.SSTR/TK.RGD, a Novel Infectivity-Enhanced Bicistronic Adenovirus, in Anticipation of a Phase I Clinical Trial in Patients with Recurrent Ovarian Cancer

Kellie S. Matthews, Patricia E. Noker, Baohong Tian,

Clinical Cancer Research

2009

23

Comparative Uterotrophic Effects of Endoxifen and Tamoxifen in Ovariectomized Sprague-Dawley Rats

Karen Schweikart, Sandy Eldridge, Stephanie L. Safgren,

Toxicologic Pathology

2014

19

Preclinical pharmacokinetic, toxicological and biomarker evaluation of SR16157, a novel dual-acting steroid sulfatase inhibitor and selective estrogen receptor modulator

Linda Rausch, Carol Green, Karen L. Steinmetz,

Cancer Chemotherapy and Pharmacology

2010

18

Page 1